Investors - Press Releases
|View printer-friendly version|
CMS’ New Value-Based Payment Program is a Catalyst for Tabula Rasa HealthCare
According to HHS Secretary
“This shift to fee-for-outcomes presents an enormous opportunity for TRHC to benefit more patients and providers with its novel medication decision support tools and MedWise™ software, which analyzes multi-drug regimens to detect and reduce dangerous drug interactions,” said
According to the CMS, their experience with innovative models, programs and demonstrations to date have shown that when incentives for primary care clinicians are aligned to reward the provision of high value care, the quality and cost effectiveness of patient care improves.
As part of the policy changes, there will be a Direct Contracting (DC) payment model option aimed to engage a wider variety of organizations that have experience taking on financial risk and serving larger patient populations, such as Accountable Care Organizations,
Currently, TRHC provides a variety of services to health plans, Medicare Advantage Part D Plans, accountable care organizations, at-risk provider organizations, hospitals and community pharmacy markets, reaching over 10,000 pharmacies and more than 15,000 pharmacists. TRHC’s proprietary Medication Risk Mitigation technology, MedWise, has been proven to prevent adverse drug events – the fourth leading cause of death in the U.S. – and has been shown to correlate directly with better quality of care and lower medical expenditures.
This press release includes forward-looking statements that we believe to be reasonable as of today’s date, including statements regarding Medication Risk Mitigation technology. Such statements are identified by use of the words “anticipates,” “believes,” “estimates,” “expects,” “intends,” “plans,” “predicts,” “projects,” “should,” and similar expressions. These forward-looking statements are based on management’s expectations and assumptions as of the date of this press release. Actual results might differ materially from those explicit or implicit in the forward-looking statements. Important factors that could cause actual results to differ materially include: the need to innovate and provide useful products and services; risks related to changing healthcare and other applicable regulations; increasing consolidation in the healthcare industry; managing our growth effectively; our ability to adequately protect our intellectual property; and the other risk factors set forth from time to time in our filings with the SEC, including those factors discussed under the caption “Risk Factors” in our most recent annual report on Form 10-K, filed with the
|Amanda Hundt||Bob East or Asher Dewhurst|
|T: (415) firstname.lastname@example.org|
||T: (443) 213-0500|
Source: Tabula Rasa HealthCare, Inc.